Business · 18/06/2007
FDA to Host Public Workshop on Licensure of Apheresis Blood Products
The US Food and Drug Administration (FDA) will host a public workshop to discuss the licensure of apheresis blood products, a process in which plasma is separated from whole blood to create life-saving therapies.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →